The Sahlgrenska University Hospital is a hospital network associated with the Sahlgrenska Academy at the University of Gothenburg in Gothenburg, Sweden. With 17,000 employees the hospital is the largest hospital in Sweden by a considerable margin, and the second largest hospital in Europe.

There are 2,000 beds in Department of Oncology, Sahlgrenska University Hospital.

During the past decade, Department of Oncology, Sahlgrenska University Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Oncology, Sahlgrenska University Hospital" #1 sponsor was "Ass. Prof. Jan Nyman" with 2 trials, followed by "Lund University Hospital" with 2 trials sponsored, "Collaborative Group for Adrenocortical Carcinoma Treatment" with 1 trials sponsored, "Swedish Lung Cancer Study Group" with 1 trials sponsored and "The Christie NHS Foundation Trust" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Oncology, Sahlgrenska University Hospital" #1 collaborator was "Danish Breast Cancer Cooperative Group" with 1 trials as a collaborator, "Finnish Breast Cancer Group" with 1 trials as a collaborator, "German Federal Ministry of Education and Research" with 1 trials as a collaborator, "Icelandic Breast Cancer Group" with 1 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Department of Oncology, Sahlgrenska University Hospital" are "Non Small Cell Lung Cancer" (2 trials), "Breast Cancer" (1 trials), "Breast Cancer Metastatic" (1 trials), "Carcinoma, Adrenal Cortical" (1 trials) and "Cardiotoxicity" (1 trials). Many other conditions were trialed in "Department of Oncology, Sahlgrenska University Hospital" in a lesser frequency.

Most popular intervention types in "Department of Oncology, Sahlgrenska University Hospital" are "Drug" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "177Lu-DOTA-TATE" (1 trials), "Cisplatin" (1 trials), "Dose escalated radiochemotherapy up to 84 Gy" (1 trials), "Doxorubicin" (1 trials) and "Etoposide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Oncology, Sahlgrenska University Hospital" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Department of Oncology, Sahlgrenska University Hospital". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Department of Oncology, Sahlgrenska University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Oncology, Sahlgrenska University Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".